 |
| BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence. |
|---|
|
   |
|
|
 Hot Stock to Watch
|
Company: Medical Marijuana Inc. (Pink Sheets: MJNA)
|
End of Day:
Price: 0.039
Change (%): + 0.00 (0.00)
Volume: 4,011,832 |
 |
Photo Release -- Medical Marijuana, Inc.'s Dixie Botanicals(TM) Unveils Dixie Stix CBD Hemp Oil at Los Angeles Global Cannabis Expo; Addresses Industry Challenge: Standardization
Dixie Botanicals(TM), a Widely Recognized Cannabis Brand, Launches Dixie Stix(TM) New CBD Hemp Oil Oral Applicator Product While Addressing Cannabis Industry Challenges: Consistency and Standardization
SAN DIEGO, Sept. 16, 2015 (GLOBE NEWSWIRE) - One of the cannabis industry’s most visible brands, Dixie Botanicals™, is proud to announce their newest hemp cannabidiol (CBD) oil whole food product: Dixie Stix. The all-natural, non-GMO hemp stalk oil is blended with medium chain triglyceride (MCT) oil and delivered in a convenient handheld tube. With this new twist dial tube packaging, Dixie Botanicals™ is also addressing a major challenge facing the cannabis industry: standardization.
“Our customers deserve the highest quality all-natural hemp CBD oil products in the world,” states Marcos Agramont, Director of Operations for HempMeds, the master distributor of Dixie Botanicals. “Consumers expect to receive a product with the same hemp CBD oil volume, quality, taste and consistency. As with other natural products, standardization can be a challenge - and the cannabis industry is no different. Between Dixie Botanicals’ unique formulations to the wide variety of innovative delivery methods and retail-ready commercial packaging, Dixie Botanicals addresses and overcomes major challenges that face the cannabis industry: quality assurance and standardization.”
Continue Reading
|
 Yesterday's Top Performer
|
Company: Terra Tech Corp (OTCQB: TRTC)
|
End of Day:
Price: 0.1123
Change (%): + 0.0073 (6.95)
Volume: 1,251,704 |
 |
OTC Markets Group Welcomes Terra Tech to OTCQX
NEW YORK, Sept. 16, 2015 /PRNewswire/ - OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial markets, today announced Terra Tech Corp. (OTCQX: TRTC), a company specializing in controlled environment agricultural technologies, has qualified to trade on the OTCQX® Best Market.
“Terra Tech joining the OTCQX Best Market is a strong validation of our management team and growth value,” said Derek Peterson, CEO of Terra Tech. “As we continue to execute on our business strategy, we believe trading on OTCQX will help drive liquidity, broaden our existing stockholder base, and elevate the visibility of Terra Tech’s investment proposition among new investors.”
Continue Reading |
Other Small Cap News
|
Company: Sparta Commercial Services, Inc. (OTCQB: SRCO)
|
iMobileApp Customer Base Continues to Expand
New York, NY., Sept. 16, 2015 (GLOBE NEWSWIRE) -- New York, NY. September 16, 2015. - Sparta Commercial Services, Inc. (OTCQB: SRCO), reported today that the client base for Sparta's iMobileApp product continues to grow. The Company stated that the interest and demand for the iMobileApp continues, as evidenced by the recently launched iMobileApps listed below:
Anthony Havens, Sparta's CEO, said, "We are particularly pleased with the relationship forged with QwikWash America! When our mobile app development team heard that they were not happy with their current website, we formed a plan and quickly designed and implemented a site which included all of the features they were looking for."
Continue Reading
|
Company: Surna, Inc. (OTCQB: SRNA)
|
Surna, Inc. Announces Pre-order Sales and Operational Update on the Surna Reflector
BOULDER, Colorado, September 16, 2015 /PRNewswire/ -- Surna, Inc. (OTCQB: SRNA), a technology company that engineers state-of-the art equipment for controlled environment agriculture with expertise in cannabis cultivation, announced today initial pre-order numbers for the Surna Reflector and a strategic collaboration with a third party for the assembly and support of the Surna Reflector.
Cannabis cultivator, NuLeaf, has agreed to purchase eighty percent of Surna's first production build of their water-cooled Reflector in a $507,795 deal. "We're excited to be leading the drive for innovation in the cannabis sector with the installation of over 400 of Surna's Reflectors in our new facility in Reno," stated Tim Schick, Chief Executive Officer of NuLeaf. The Reflectors will be installed as a subsection of a complete Surna climate control system. The remainder of the first production Reflector build is intended to go to smaller facilities.
Continue Reading
|
Company: Regen BioPharma, Inc. (OTCBB: RGBP)
|
Regen BioPharma, Inc. Files Utility Patent Application on Immune Based Therapy for Cancer
Company Advances Immuno-Oncology Position Using Agents That Stimulate Dendritic Cells In Vivo
SAN DIEGO, September 16, 2015 /PRNewswire/ -- Regen BioPharma, Inc. (OTCBB: RGBP) and (PINK: RGBP) announced today the filing of a utility patent application with the United States Patent and Trademark Office covering a novel cancer immunotherapy which induces activation of dendritic cells inside the body in order to stimulate immune-based rejection of cancer. The application builds on Regen's existing expertise in the area of dendritic cells including publications together with scientific advisory board member Dr. Wei-Ping Min (1-3), Professor at the University of Western Ontario, as well as purchase of issued patent # 8,389,708.
Continue Reading
|
Company: Endonovo Therapeutics, Inc. (OTCQB: ENDV)
|
Endonovo Therapeutics Announces Corporate Patent Licensing Program
LOS ANGELES, CA--(Marketwired - Sep 16, 2015) - Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a biotechnology company developing non-invasive, bioelectronic products with anti-inflammatory properties designed to promote regeneration in damaged tissue and organs, announced today the commencement of the Company's patent licensing program. The first of several patent applications filed with the United States Patent and Trademark Office is currently available for licensing to potential corporate partners.
Initially, the technology being offered by the Company for licensing opportunities is a composition and process patent. The patent covers a composition and process for creating a cell mixture derived from a portion of the umbilical cord co-cultured with adipose-derived stem cells. The resulting mixture provides a rich source of highly proliferative, biologically potent, immunosuppressive and non-alloreactive cells that display neither of the major histocompatibility markers (HLA double negative). Therefore, the cell mixture can be used as either an autologous or an allogeneic off-the-shelf source for cell-based therapeutics.
Continue Reading
|
Company: Cybergy Holdings, Inc. (OTCQB: CYBG)
|
Cybergy to Hold Webinar Events in Advance of Upcoming SmartFile Release
ENGLEWOOD, Colo.--(BUSINESS WIRE)--Cybergy Labs, a wholly-owned subsidiary of Cybergy Holdings, Inc. (OTCQB: CYBG), today announced that the Company will be hosting a series of teach-in events to familiarize new users with its proprietary digital sensor system, SmartFile - The Internet of Documents.
As part of this process, Cybergy Labs will be offering free accounts of its software to selected individuals to continue with its beta testing process while also allowing new parties access to this important cybersecurity-enhancing product.
Continue Reading |
Market News
|
By Jeff Cox: CNBC
|
When the Fed raises rates, here's what happens
A rate hike will come and the bull market will stumble, bond yields will climb and the economy will slip into a recession.
This we know.
For the economy specifically, history offers little guide about timing. A recession has come as quickly as 11 months after the first rate hike and as long as 86 months.
Continue Reading
|
By Peter Schacknow: CNBC
|
Early movers: FDX, HPQ, ORCL, FIT, HSY, BUD, LINKD, SIRO & more
Check out which companies are making headlines before the bell:
FedEx - FedEx reported quarterly profit of $2.42 per share, 4 cents below estimates, with revenue matching forecasts. CEO Fred Smith said the company is doing well considering weaker than expected global economic conditions. Separately, FedEx will increase rates by 4.9 percent at its FedEx Express service, effective January 4.
Oracle - The stock was upgraded to "buy" from "neutral" at SunTrust, which cites increasing opportunities for Oracle's cloud-based business as well as valuation. Oracle is scheduled to report quarterly numbers after today's closing bell.
Fitbit - Retailer Target is offering Fitbit activity trackers to its 335,000 US employees in one of Fitbit's largest corporate deals in its history.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
